Japan· JP-3399416G1028
ペグフィルグラスチム（遺伝子組換え）［ペグフィルグラスチム後続１］
A medicinal product containing ペグフィルグラスチム（遺伝子組換え）［ペグフィルグラスチム後続１］, registered in Japan by 持田製薬販売, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- ペグフィルグラスチム（遺伝子組換え）［ペグフィルグラスチム後続１］
- Manufacturer
- 持田製薬販売
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
ペグフィルグラスチム（遺伝子組換え）［ペグフィルグラスチム後続１］ in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandCegfilaMundipharma Corporation (Ireland) Limited
- United StatesARMLUPEGLupin Pharmaceuticals, Inc.
- CzechiaCEGFILAMundipharma Corporation (Ireland) Limited, Dublin
- BelgiumCegfila 6 mgMundipharma Corporation
- NetherlandsCegfila 6 mg, oplossing voor injectie in voorgevulde spuitMundipharma Corporation (Ireland) Limited
- PolandCegfilaMundipharma Corporation (Ireland) Limited
- SwedenCegfila 6 mg Injektionsvätska, lösning i förfylld sprutaMundipharma Corporation (Ireland) Limited
- FranceCEGFILA 6 mg, solution injectable en seringue préremplieMUNDIPHARMA CORPORATION (IRELAND)
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Pelmeg
- Iceland · Cegfila, Dyrupeg
- Liechtenstein · Cegfila, Dyrupeg
- Norway · Cegfila, Dyrupeg
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c81d0b3c-d496-49ba-b21e-c8abe778c9fa GET /v1/drugs/c81d0b3c-d496-49ba-b21e-c8abe778c9fa?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "３．６ｍｇ０．３６ｍＬ１筒",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "3399416G1028",
"category": "注射薬",
"price_yen": 54924,
"generic_name": "ペグフィルグラスチム（遺伝子組換え）［ペグフィルグラスチム後続１］",
"product_name_jp": null,
"therapeutic_class": "3399",
"transitional_expiry": null
}See everything about ペグフィルグラスチム（遺伝子組換え）［ペグフィルグラスチム後続１］.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.